Lornoxicam
-
Lornoxicam
structure -
-
CAS No:
70374-39-9
-
Formula:
C13H10ClN3O4S2
-
Chemical Name:
Lornoxicam
-
Synonyms:
2H-Thieno[2,3-e]-1,2-thiazine-3-carboxamide,6-chloro-4-hydroxy-2-methyl-N-2-pyridinyl-,1,1-dioxide;Lornoxicam;Chlortenoxicam;Ro 13-9297;TS 110;Telos;Xefo;Xefocam;Lorcam;Lofecam;Fulactive
- Categories:
-
CAS No:
Description
Lornoxicam, a COX-1 and COX-2 inhibitor, is a new nonsteroidal anti-inflammatory drug (NSAID).Target: COXLornoxicam showed a balanced inhibition of COX-1/-2 exhibiting the lowest IC50 (0.005 microM/0.008 microM) of the large panel of NSAIDs tested. lornoxicam showed a marked inhibition of IL-6 formation (IC50 54 microM) while the formation ofTNF-alpha, IL-1beta and IL-8 was only moderately affected [1]. Lornoxicam is effective in the treatment of patients with activated osteoarthritis; t
Lornoxicam is a thienothiazine-derived monocarboxylic acid amide obtained by formal condensation of the carboxy group of 6-chloro-4-hydroxy-2-methylthieno[2,3-e][1,2]thiazine-3-carboxylic acid 1,1-dioxide with the amino group of 2-aminopyridine. Used for the treatment of pain, primarily resulting from inflammatory diseases of the joints, osteoarthritis, surgery, sciatica and other inflammations. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic and an antipyretic. It is a thienothiazine, a member of pyridines, a monocarboxylic acid amide, an organochlorine compound and a heteroaryl hydroxy compound.|Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. Lornoxicam differs from other oxicam compounds in its potent inhibition of prostaglandin biosynthesis, a property that explains the particularly pronounced efficacy of the drug. Lornoxicam is approved for use in Japan.|Lornoxicam is an orally bioavailable oxicam and non-steroidal anti-inflammatory drug (NSAID), with analgesic, anti-pyretic, anti-thrombotic and anti-inflammatory activities. Upon oral administration, lornoxicam binds to and inhibits the activity of the cyclooxygenase enzymes (COX) type 1 (COX-1) and type 2 (COX-2). This blocks COX-mediated signaling pathways, which leads to reduced prostaglandin and thromboxane production and decreased pain, fever and inflammation.
Lornoxicam Basic Attributes
371.82
371.82
1308068-626-2
ER09126G7A
759620
DTXSID6046133
C72140
M - Musculo-skeletal system
2934999090
Characteristics
136
2.1
faint yellow to dark yellow
1.7±0.1 g/cm3
225-230 °C (decomp)
1.741
DMSO: >5mg/mL (warmed)
-20°C Freezer
LD50 orally in mice, rats, rabbits, dogs, monkeys: >10 mg/kg (Pruss)
Safety Information
IRRITANT
UN 2811 6.1 / PGII
3
36/37/38-28
26-36-45-36/37-28
XJ9095000
Xi,T+
P264-P301 + P310
H300
|Danger|H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]|P264, P270, P301+P310, P321, P330, P405, and P501|Aggregated GHS information provided by 41 companies from 2 notifications to the ECHA C&L Inventory.
Drug Information
For the treatment of acute mild to moderate pain, as well as pain and inflammation of the joints caused by certain types of rheumatic diseases.
Lornoxicam is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the oxicam class. As with other NSAIDS, lornoxicam is a potent inhibitor of the cyclooxgenase enzymes, which are responsible for catalyzing the formation of prostaglandins (act as messenger molecules in the process of inflammation) and thromboxane from arachidonic acid. Unlike some NSAIDS, lornoxicam's inhibition of cyclooxygenase does not lead to an increase in leukotriene formation, meaning that arachidonic acid is not moved to the 5-lipoxygenase cascade, resulting in the minimization of the risk of adverse events.
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Lornoxicam is absorbed rapidly and almost completely from the GI tract (90-100%).
Lornoxicam is metabolized completely by cyp 2C9 with the principal metabolite being 5'-hydroxy-lornoxicam and only negligible amounts of intact lornoxicam are excreted unchanged in the urine. Approximately 2/3 of the drug is eliminated via the liver and 1/3 via the kidneys in the active form.|Lornoxicam has known human metabolites that include 5'-Hydroxylornoxicam.
3-5 hours
Like other NSAIDS, lornoxicam's anti-inflammatory and analgesic activity is related to its inhibitory action on prostaglandin and thromboxane synthesis through the inhibition of both COX-1 and COX-2. This leads to the reduction of inflammation, pain, fever, and swelling, which are mediated by prostaglandins. However, the exact mechanism of lornoxicam, like that of the other NSAIDs, has not been fully determined.
chlortenoxicam
Lornoxicam Use and Manufacturing
Cyclooxygenase inhibitor; structurally similar to tenoxicam. Anti-inflammatory; analgesic
Computed Properties
Molecular Weight:371.8
XLogP3:2.1
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:2
Exact Mass:370.9801258
Monoisotopic Mass:370.9801258
Topological Polar Surface Area:136
Heavy Atom Count:23
Complexity:634
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Extract from the above information
Registered Holders
-
Beijing Lunarsun Pharmaceutical Co., Ltd.
Active
China
-
Heilongjiang Wusulijiang Pharmaceutical Co., Ltd. Yingchun Branch
Active
China
-
Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Co., Ltd.
Active
China
Recommended Suppliers of Lornoxicam
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP -
CN
3 YRS
Business licensedTrader Supplier of vitaminInquiryUnit Price: $5-6 /MT FOBCAS No.: 70374-39-9Grade: Pharmaceutical GradeContent: 99% -
CN
3 YRS
Business licensedTrader Supplier of api,Intermediates,Organic Chemistry,Inorganic Chemistry,Daily Chemicals,Cosmetic Raw Materals,CATALYST AND AUXILIARY,FLAVORS AND FRAGRANCES,Chemical Pesticides,ADDITIVE -
CN
3 YRS
Business licensedTrader Supplier of chemicalInquiryCAS No.: 70374-39-9Grade: Chemical GradeContent: 99% -
CN
3 YRS
Business licensedTrader Supplier of CHEMICALS,REAGENTSInquiryCAS No.: 70374-39-9Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
5-HYDROXY LORNOXICAM
123252-96-0
-
2,4-Dichloro-3-methylpyridine
132097-09-7
-
2,6-Dibromo-3-fluoropyridine
41404-59-5
-
Triphenylacetic acid Formula
595-91-5
-
3-Chloro-5-fluoro-4-pyridinecarboxylic acid Formula
514798-03-9
-
2-CHLORO-4-PHENYLPYRIDINE Formula
42260-39-9
-
2-Phenyl-4-quinolinecarboxylic acid Structure
132-60-5
-
(-)-Flurbiprofen Structure
51543-40-9
-
What is Naproxen sodium
26159-34-2
-
What is Glycine, N,N-diethyl-, 4-(acetylamino)phenyl ester, hydrochloride (1:1)
66532-86-3